Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -20.35 | N/A |
PEG Ratio (TTM) | -0.21 | N/A |
P/S Ratio (TTM) | 35.76 | N/A |
P/B Ratio (TTM) | 5.22 | N/A |
P/FCF Ratio (TTM) | -4.46 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -12.64% | N/A |
ROE (TTM) | -27.90% | N/A |
Net Profit Margin (TTM) | -229.67% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1.60% | -2,682.56% | N/A |
Revenue | -9.01% | N/A | N/A |
Net Income | -4.64% | -1,353.73% | N/A |
Cash Flow | -5.45% | -7,706.21% | N/A |
Health (42%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.51 | N/A |
Quick Ratio (TTM) | 5.51 | N/A |
D/E Ratio (TTM) | 0.48 | N/A |
Interest Coverage (TTM) | -110.12 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |